Acute and 3-month effects of microcrystalline hydroxyapatite, calcium citrate and calcium carbonate on serum calcium and markers of bone turnover: A randomised controlled trial in postmenopausal women

British Journal of Nutrition

Volumn 112, Issue 10, 2014, Pages 1611-1620

  Bristow, Sarah M ^a   Gamble, Greg D ^a   Stewart, Angela ^a   Horne, Lauren ^a   House, Meaghan E ^a   Aati, Opetaia ^a   Mihov, Borislav ^a   Horne, Anne M ^a   Reid, Ian R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Bone turnover; Calcium supplements; Randomised trials; Serum calcium

Indexed keywords

CALCIUM; CALCIUM CARBONATE; CARBOXY TERMINAL TELOPEPTIDE; CITRATE CALCIUM; COLLAGEN; HYDROXYAPATITE; MICROCRYSTALLINE HYDROXYAPATITE; PARATHYROID HORMONE; PHOSPHATE; PLACEBO; PROCOLLAGEN TYPE 1 AMINOPROPEPTIDE; PROTEIN PRECURSOR; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; BONE DENSITY CONSERVATION AGENT; CALCIUM INTAKE; CALCIUM PHOSPHATE; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; PEPTIDE;

AGED; ARTICLE; BLOOD SAMPLING; BONE TURNOVER; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SUPPLEMENTATION; TREATMENT DURATION; BLOOD; BONE REMODELING; CALCIUM INTAKE; COMPARATIVE STUDY; DIET SUPPLEMENTATION; DRUG EFFECTS; OSTEOPOROSIS, POSTMENOPAUSAL; PHARMACOLOGY; PREVENTION AND CONTROL; THERAPEUTIC USE;

AGED; BIOLOGICAL MARKERS; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; BONE RESORPTION; CALCIUM; CALCIUM CARBONATE; CALCIUM CITRATE; CALCIUM PHOSPHATES; CALCIUM, DIETARY; COLLAGEN TYPE I; DIETARY SUPPLEMENTS; DURAPATITE; FEMALE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; PEPTIDES; PHOSPHATES; POSTMENOPAUSE;

EID: 84922392381     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114514002785     Document Type: Article

References (47)

1. Bolland MJ, Grey A, Gamble GD, et al. (2011) Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am J Clin Nutr 94, 1144-1149.
2. Li K, Kaaks R, Linseisen J, et al. (2012) Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition study (EPICHeidelberg). Heart 98, 920-925.
3. Xiao Q, Murphy RA, Houston DK, et al. (2013) Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med 173, 639-646.
4. Iso H, Stampfer MJ, Manson JE, et al. (1999) Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke 30, 1772-1779.
5. Karp HJ, Ketola ME & Lamberg-Allardt CJ (2009) Acute effects of calcium carbonate, calcium citrate and potassium citrate on markers of calcium and bone metabolism in young women. Br J Nutr 102, 1341-1347.
6. Heaney RP, Dowell MS, Bierman J, et al. (2001) Absorbability and cost effectiveness in calcium supplementation. J Am Coll Nutr 20, 239-246.
7. Karkkainen MU, Wiersma JW & Lamberg-Allardt CJ (1997) Postprandial parathyroid hormone response to four calciumrich foodstuffs. Am J Clin Nutr 65, 1726-1730.
8. Slinin Y, Blackwell T, Ishani A, et al. (2011) Serum calcium, phosphorus and cardiovascular events in post-menopausal women. Int J Cardiol 149, 335-340.
9. Jorde R, Sundsfjord J, Fitzgerald P, et al. (1999) Serum calcium and cardiovascular risk factors and diseases: the Tromso study. Hypertension 34, 484-490.
10. Shin S, Kim KJ, Chang HJ, et al. (2012) Impact of serum calcium and phosphate on coronary atherosclerosis detected by cardiac computed tomography. Eur Heart J 33, 2873-2881.
11. Reid IR & Bolland MJ (2012) Risk factors: calcium supplements and cardiovascular risk. Nat Rev Cardiol 9, 497-498.
12. Bischoff-Ferrari HA, Kiel DP, Dawson-Hughes B, et al. (2009) Dietary calcium and serum 25-hydroxyvitamin D status in relation to BMD among U.S. adults. J Bone Miner Res 24, 935-942.
13. Warensjo E, Byberg L, Melhus H, et al. (2011) Dietary calcium intake and risk of fracture and osteoporosis: prospective longitudinal cohort study. BMJ 342, d1473.
14. Bauer DC (2013) Clinical practice. Calcium supplements and fracture prevention. N Engl J Med 369, 1537-1543.
15. Manson JE & Bassuk SS (2014) Calcium supplements: do they help or harm? Menopause 21, 106-108.
16. Ma J, Johns RA & Stafford RS (2007) Americans are not meeting current calcium recommendations. Am J Clin Nutr 85, 1361-1366.
17. Pasco JA, Sanders KM, Henry MJ, et al. (2000) Calcium intakes among Australian women: Geelong Osteoporosis Study. Aust N Z J Med 30, 21-27.
18. University of Otago and Ministry of Health (2011) A Focus on Nutrition: Key Findings of the 2008/09 New Zealand Adult Nutrition Survey. Wellington: Ministry of Health.
19. Martins I, Dantas A, Guiomar S, et al. (2002) Vitamin and mineral intakes in elderly. J Nutr Health Aging 6, 63-65.
20. Lovelace HY & Barr SI (2005) Diagnosis, symptoms, and calcium intakes of individuals with self-reported lactose intolerance. J Am Coll Nutr 24, 51-57.
21. Reid IR, Schooler BA, Hannan SF, et al. (1986) The acute biochemical effects of four proprietary calcium preparations. Aust N Z J Med 16, 193-197.
22. Tang BM, Eslick GD, Nowson C, et al. (2007) Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 370, 657-666.
23. Angus RM, Sambrook PN, Pocock NA, et al. (1989) A simple method for assessing calcium intake in Caucasian women. J Am Diet Assoc 89, 209-214.
24. Deroisy R, Zartarian M, Meurmans L, et al. (1997) Acute changes in serum calcium and parathyroid hormone circulating levels induced by the oral intake of five currently available calcium salts in healthy male volunteers. Clin Rheumatol 16, 249-253.
25. Horowitz M, Wishart JM, Goh D, et al. (1994) Oral calcium suppresses biochemical markers of bone resorption in normal men. Am J Clin Nutr 60, 965-968.
26. Thomas SD, Need AG, Tucker G, et al. (2008) Suppression of parathyroid hormone and bone resorption by calcium carbonate and calcium citrate in postmenopausal women. Calcif Tissue Int 83, 81-84.
27. Bolland MJ, Grey A, Avenell A, et al. (2011) Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ 342, d2040.
28. Buclin T, Jacquet AF & Burckhardt P (1986) Intestinal absorption of calcium gluconate and oseine-mineral complex: an evaluation by conventional analyses. Schweiz Med Wochenschr 116, 1780-1783.
29. Nicar MJ & Pak CY (1985) Calcium bioavailability from calcium carbonate and calcium citrate. J Clin Endocrinol Metab 61, 391-393.
30. Harvey JA, Zobitz MM & Pak CY (1988) Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate. J Bone Miner Res 3, 253-258.
31. Recker RR (1985) Calcium absorption and achlorhydria. N Engl J Med 313, 70-73.
32. Heaney RP, Recker RR & Weaver CM (1990) Absorbability of calcium sources: the limited role of solubility. Calcif Tissue Int 46, 300-304.
33. Ekman M, Reizenstein P, Teigen SW, et al. (1991) Comparative absorption of calcium from carbonate tablets, lactogluconate/carbonate effervescent tablet, and chloride solution. Bone 12, 93-97.
34. el-Hajj Fuleihan G, Klerman EB, Brown EN, et al. (1997) The parathyroid hormone circadian rhythm is truly endogenous-a general clinical research center study. J Clin Endocrinol Metab 82, 281-286.
35. Greenspan SL, Dresner-Pollak R, Parker RA, et al. (1997) Diurnal variation of bone mineral turnover in elderly men and women. Calcif Tissue Int 60, 419-423.
36. Wichers M, Schmidt E, Bidlingmaier F, et al. (1999) Diurnal rhythm of CrossLaps in human serum. Clin Chem 45, 1858-1860.
37. Qvist P, Christgau S, Pedersen BJ, et al. (2002) Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting. Bone 31, 57-61.
38. Ahmad AM, Hopkins MT, Fraser WD, et al. (2003) Parathyroid hormone secretory pattern, circulating activity, and effect on bone turnover in adult growth hormone deficiency. Bone 32, 170-179.
39. Riggs BL, O'Fallon WM, Muhs J, et al. (1998) Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res 13, 168-174.
40. Reid IR, Mason B, Horne A, et al. (2006) Randomized controlled trial of calcium in healthy older women. Am J Med 119, 777-785.
41. Reid IR, Ames R, Mason B, et al. (2008) Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men. Arch Intern Med 168, 2276-2282.
42. Ruegsegger P, Keller A & Dambacher MA (1995) Comparison of the treatment effects of ossein-hydroxyapatite compound and calcium carbonate in osteoporotic females. Osteoporos Int 5, 30-34.
43. Pelayo I, Haya J, De la Cruz JJ, et al. (2008) Raloxifene plus ossein-hydroxyapatite compound versus raloxifene plus calcium carbonate to control bone loss in postmenopausal women: a randomized trial. Menopause 15, 1132-1138.
44. Ciria-Recasens M, Blanch-Rubio J, Coll-Batet M, et al. (2011) Comparison of the effects of ossein-hydroxyapatite complex and calcium carbonate on bone metabolism in women with senile osteoporosis: a randomized, open-label, parallelgroup, controlled, prospective study. Clin Drug Investig 31, 817-824.
45. Foley RN, Collins AJ, Ishani A, et al. (2008) Calciumphosphate levels and cardiovascular disease in communitydwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 156, 556-563.
46. Foley RN, Collins AJ, Herzog CA, et al. (2009) Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 20, 397-404.
47. Dhingra R, Sullivan LM, Fox CS, et al. (2007) Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167, 879-885.